Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
50.9M
-
Shares change
-
+4.74M
-
Total reported value, excl. options
-
$99.4M
-
Value change
-
+$7.13M
-
Put/Call ratio
-
0.45
-
Number of buys
-
49
-
Number of sells
-
-51
-
Price
-
$1.95
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2023
115 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.9M shares
of 161M outstanding shares and own 31.73% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (7.57M shares), Redmile Group, LLC (6.86M shares), BlackRock Inc. (6.21M shares), VANGUARD GROUP INC (4.05M shares), Versant Venture Management, LLC (3.56M shares), Avidity Partners Management LP (2.77M shares), Frazier Life Sciences Management, L.P. (2.4M shares), Balyasny Asset Management L.P. (1.88M shares), MORGAN STANLEY (1.78M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.68M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.